Pediatric Endocrinology News

Younger teens at risk for severe obesity are just as likely as older adolescents to benefit from bariatric surgery and should not be denied consideration for the procedure on the basis of age, according to a study published in Pediatrics.

Children in Sweden who were treated with recombinant human growth hormone, or rhGH, have an increased risk for cardiovascular events in adulthood vs. controls; however, the absolute risk remains low, according to study data.

A modified version of an FDA-approved close-loop insulin delivery system may be effective for children aged 2 to 5 years with type 1 diabetes, according to study data published in Diabetes Technology & Therapeutics.

Gonadotropin-releasing hormone analogue therapy is linked to improvement in final adult height and reduced BMI in central precocious puberty, but evidence for other key outcomes is “weak” to indicate benefits or adverse effects, data show.

Two professional endocrine societies are formally opposing legislative efforts to block transgender people from accessing gender-affirming medical and surgical care, after dozens of state bills threatened to criminalize such therapies.

Health care conferences around the world looked completely different in 2020 as the COVID-19 pandemic forced organizations to conduct virtual meetings.

Nearly 20% of pediatric brain tumors occur in the pituitary region, and more than two-thirds of pituitary region tumors were present in girls, according to study findings published in Pituitary.

Fecal microbiome transfer led to a mean reduction in android-to-gynoid fat ratio and a resolution of metabolic syndrome in a cohort of adolescents with obesity, according to randomized controlled trial data published in JAMA Network Open.

Increasing lifetime exposure to antimicrobial agents was associated with increasing likelihood for overweight and obesity among older children, according to a study published in Pediatric Obesity.

Children conceived after in vitro fertilization or intracytoplasmic sperm injection are more likely to have metabolic dysfunction during childhood than those conceived without assistive technology, according to study data.